226 related articles for article (PubMed ID: 30107830)
1. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.
Gonçalves AP; Almeida LT; Rezende IMd; Fradico JRB; Pereira LS; Ramalho DB; Pascoal Xavier MA; Calzavara Silva CE; Monath TP; LaBeaud AD; Drumond BP; Campi-Azevedo AC; Martins-Filho OA; Teixeira-Carvalho A; Alves PA;
Microbiol Spectr; 2024 May; 12(5):e0370323. PubMed ID: 38511952
[TBL] [Abstract][Full Text] [Related]
5. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.
Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R
Virol J; 2019 May; 16(1):65. PubMed ID: 31101058
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses.
Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM
Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR
Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430
[TBL] [Abstract][Full Text] [Related]
8. Reemergence of yellow fever in Ethiopia after 50 years, 2013: epidemiological and entomological investigations.
Lilay A; Asamene N; Bekele A; Mengesha M; Wendabeku M; Tareke I; Girmay A; Wuletaw Y; Adossa A; Ba Y; Sall A; Jima D; Mengesha D
BMC Infect Dis; 2017 May; 17(1):343. PubMed ID: 28506254
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.
Willcox AC; Collins MH; Jadi R; Keeler C; Parr JB; Mumba D; Kashamuka M; Tshefu A; de Silva AM; Meshnick SR
Am J Trop Med Hyg; 2018 Sep; 99(3):756-763. PubMed ID: 29988000
[TBL] [Abstract][Full Text] [Related]
10. Yellow fever risk assessment in the Central African Republic.
Staples JE; Diallo M; Janusz KB; Manengu C; Lewis RF; Perea W; Yactayo S; Sall AA;
Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):608-15. PubMed ID: 24947520
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model.
Shinde DP; Walker J; Reyna RA; Scharton D; Mitchell B; Dulaney E; Bonam SR; Hu H; Plante JA; Plante KS; Weaver SC
Viruses; 2024 May; 16(6):. PubMed ID: 38932129
[TBL] [Abstract][Full Text] [Related]
12. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Staples JE; Gershman M; Fischer M;
MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
[TBL] [Abstract][Full Text] [Related]
13. Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Yamamura AY; Lima SMB; Simões M; Campos FMF; de Castro Zacche Tonini A; Lemos EM; Brum RC; de Noronha TG; Freire MS; Maia MLS; Camacho LAB; Rios M; Chancey C; Romano A; Domingues CM; Teixeira-Carvalho A; Martins-Filho OA;
J Immunol Methods; 2017 Sep; 448():9-20. PubMed ID: 28514646
[TBL] [Abstract][Full Text] [Related]
14. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
[TBL] [Abstract][Full Text] [Related]
15. Dengue virus seroprevalence among febrile patients in Bamako, Mali: results of a 2006 surveillance study.
Phoutrides EK; Coulibaly MB; George CM; Sacko A; Traore S; Bessoff K; Wiley MR; Kolivras KN; Adelman Z; Traore M; Hunsperger EA
Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1479-85. PubMed ID: 21767159
[TBL] [Abstract][Full Text] [Related]
16. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
Lindsey NP; Horiuchi KA; Fulton C; Panella AJ; Kosoy OI; Velez JO; Krow-Lucal ER; Fischer M; Staples JE
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346562
[TBL] [Abstract][Full Text] [Related]
17. The response to re-emergence of yellow fever in Nigeria, 2017.
Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test].
Ayturan S; Aydoğan S; Ergünay K; Ozcebe OI; Us D
Mikrobiyol Bul; 2011 Jan; 45(1):113-24. PubMed ID: 21341166
[TBL] [Abstract][Full Text] [Related]
19. An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005.
Gould LH; Osman MS; Farnon EC; Griffith KS; Godsey MS; Karch S; Mulenda B; El Kholy A; Grandesso F; de Radiguès X; Brair ME; Briand S; El Tayeb el SM; Hayes EB; Zeller H; Perea W
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1247-54. PubMed ID: 18502458
[TBL] [Abstract][Full Text] [Related]
20. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
